摘要
目的:研究前列腺癌骨转移患者血清ODF、OCIF含量及其临床价值。方法:采集前列腺癌骨转移骨转移和非骨转移患者的血清,检测ODF、OCIF含量;培养前列腺癌DU145细胞,用不同浓度的ODF、OCIF处理后,检测细胞迁移率以及LASS-2/TMSG-1的mRNA含量。结果:骨转移组血清中ODF、OCIF的含量以及ODF/OCIF的比值均高于非骨转移组(P<0.05);骨转移病灶数目越多,血清ODF含量越高、而OCIF含量越低;ODF处理能够剂量依赖性地增加前列腺癌细胞迁移率、减少LASS-2/TMSG-1的mRNA含量;OCIF处理能够剂量依赖性地降低前列腺癌细胞迁移率、增加LASS-2/TMSG-1的mRNA含量。结论:前列腺癌骨转移患者血清中ODF、OCIF含量均升高,且以ODF升高的效应更为明显;ODF具有促进前列腺癌细胞迁移的作用、而OCIF具有抑制作用。
Objective:To detect serum ODF and OCIF contents in prostate cancer patients with bone metastasis and its clinical value.Methods:Serum of prostate cancer patients with and without bone metastasis was collected,then ODF and OCIF contents were detected;prostate cancer DU145 cells were cultured and treated with different concentrations of ODF and OCIF,then cell migration rates as well as mRNA contents of LASS-2/TMSG-1were detected.Results:Serum ODF and OCIF contents as well as ODF/OCIF ratio of bone metastasis group were all higher than those of non-bone metastasis group;the more the number of metastatic bone lesions was,the higher the serum ODF content was,and the lower the OCIF content was;ODF treatment could increase prostate cancer cell migration rates and decrease mRNA contents of LASS-2/TMSG-1on dose-dependent manner;OCIF treatment could decrease prostate cancer cell migration rates and increase mRNA contents of LASS-2/TMSG-1on dose-dependent manner.Conclusion:Serum ODF and OCIF contents in prostate cancer patients with bone metastasis increase,and ODF increase effect is more obvious;ODF has promoting effect on prostate cancer cell migration while OCIF has inhibiting effect.
出处
《海南医学院学报》
CAS
2015年第12期1690-1692,1696,共4页
Journal of Hainan Medical University
基金
湖北省科技计划项目(2012JK2056)~~
关键词
前列腺癌
骨转移
破骨细胞
细胞迁移
Prostate cancer
Bone metastasis
Osteoclast differentiation factor
Osteoclastogenesis inhibitory factor
Migration